All In MedTech

FDA Clearance Tracker · P040038

XACT CAROTID STENT SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Sep 6, 2005 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Sep 6, 2005

Approved

Time to decision

368 days

Received Sep 3, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P040038
Device name
XACT CAROTID STENT SYSTEM
Applicant location
Santa Clara, CA
Received
Sep 3, 2004
Decided
Sep 6, 2005
Decision
Approved
Supplements
48 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NIM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE XACT CAROTID STENT SYSTEM. THE XACT CAROTID STENT SYSTEM, USED IN CONJUNCTION WITH THE ABBOTT VASCULAR DEVICES EMBOLIC PROTECTION SYSTEM, IS INDICATED FOR THE IMPROVEMENT OF THE LUMEN DIAMETER OF CAROTID ARTERIES IN PATIENTS CONSIDERED AT HIGH RISK FOR ADVERSE EVENTS FROM CAROTID ENDARTERECTOMY WHO REQUIRE PERCUTANEOUS CAROTID ANGIOPLASTY AND STENTING FOR OCCLUSIVE ARTERY DISEASE AND MEET THE CRITERIA OUTLINED AS FOLLOWS: 1) PATIENTS WITH CAROTID ARTERY STENOSIS (>= 50% FOR SYMPTOMATIC PATIENTS BY ULTRASOUND OR ANGIOGRAPHY OR >= 80% FOR ASYMPTOMATIC PATIENTS BY ULTRASOUND OR ANGIOGRAPHY), LOCATED BETWEEN THE ORIGIN OF THE COMMON CAROTID ARTERY AND THE INTRA-CRANIAL SEGMENT OF THE INTERNAL CAROTID ARTERY; AND 2) PATIENTS MUST HAVE A REFERENCE VESSEL DIAMETER RANGING BETWEEN 4.8 MM AND 9.1 MM AT THE TARGET LESION

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NIM. The earliest in FDA's data is P040012, decided Aug 30, 2004.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Abbott Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.